Pharma VC-Backed Incubator Cydan Launches Imara With $31.5m

With more than a year lag between the launch of its first two startups, the venture capital- and big pharma VC-backed biotechnology incubator Cydan Development Inc. is on track to reach its goal of founding five orphan drug-focused firms in four years, including its second venture, Imara Inc.